Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Methods Enzymol ; 685: 405-432, 2023.
Article in English | MEDLINE | ID: mdl-37245909

ABSTRACT

The emergence of histidine-ligated heme-dependent aromatic oxygenases (HDAOs) has greatly enriched heme chemistry, and more studies are required to appreciate the diversity found in His-ligated heme proteins. This chapter describes recent methods in probing the HDAO mechanisms in detail, along with the discussion on how they can benefit structure-function studies of other heme systems. The experimental details are centered on studies of TyrHs, followed by explanation of how the results obtained would advance the understanding of the specific enzyme and also HDAOs. Spectroscopic methods, namely, electronic absorption and EPR spectroscopies, and X-ray crystallography are valuable techniques commonly used to characterize the properties of the heme center and the nature of heme-based intermediate. Herein, we show that the combination of these tools are extremely powerful, not only because one can acquire electronic, magnetic, and conformational information from different phases, but also because of the advantages brought by spectroscopic characterization on crystal samples.


Subject(s)
Hemeproteins , Histidine , Histidine/metabolism , Heme Oxygenase (Decyclizing) , Electron Spin Resonance Spectroscopy/methods , Heme/chemistry , Heme/metabolism
2.
J Breast Cancer ; 25(6): 443-453, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36479601

ABSTRACT

PURPOSE: Breast cancer is the primary cause of cancer-related death in women. Women diagnosed with estrogen receptor (ER)-positive breast cancer have prolonged treatment durations. Owing to the paucity of research and lack of consensus regarding conception planning and pregnancy for patients with ER-positive breast cancer, we aimed to assess pregnancy and survival outcomes in women with ER-positive breast cancer during and after treatment. METHODS: We conducted a systematic review of the available studies on pregnancy after ER-positive breast cancer. The assessed outcomes included overall survival (OS), disease-free survival (DFS), hormonal therapy duration, and pregnancy outcomes. RESULTS: Ultimately, 2,669 patients from five studies were included in this study. When all breast cancer receptor subtypes were included in the analysis, pregnancy after breast cancer was associated with a time-dependent protective effect on both DFS and OS. This protective effect was not evident when examining ER-positive patients with subsequent pregnancies, and no significant differences in DFS were observed. ER-positive patients who became pregnant received significantly lower rates of hormonal therapy. Hormonal treatment at the time of pregnancy was correlated with increased rates of termination owing to concerns about teratogenic effects. CONCLUSIONS: Pregnancy after breast cancer did not significantly affect DFS in ER-positive patients over a follow-up period of 5-10 years from diagnosis, although did significantly affect hormonal treatment duration in the reviewed studies. Further analysis and in-depth studies are required to assess the effects of altered hormonal treatment times, as well as patient management related to pregnancy planning after breast cancer.

3.
Nanotechnology ; 34(1)2022 Oct 17.
Article in English | MEDLINE | ID: mdl-36179658

ABSTRACT

In the last few decades, tremendous effort has been dedicated to mimicking the efficient ionic current rectification (ICR) of biological nanopores. Nanoporous membranes and singular nanopores with ICR functionality have been fabricated using advanced, yet costly technologies. We herein demonstrate that a simple, novel, and robust ICR platform can be constructed using 80 nm silica nanoparticles and a piece of 15 nm track-etched polycarbonate membrane. Efficient ICR can be obtained when voltages of different polarities are applied across the membrane, due to the asymmetric electrophoretic migration of silica nanoparticles whose surfaces are modified with different functional groups. The effect of pore size, ionic strength, pH, voltage magnitude, and density of silica nanoparticles on the efficiency of the ICR system has been systematically investigated in this report. Our results clearly show that smaller pore, lower ionic strength, appropriate pH value, higher electrical field strength, lower density of silica nanoparticles can generally enhance the efficiency of the ICR system. The principles of this new ICR system may find many potential applications in controllable drug delivery, energy storage and water purification.

5.
Stem Cell Reports ; 9(1): 92-107, 2017 07 11.
Article in English | MEDLINE | ID: mdl-28579396

ABSTRACT

THAP1 (THAP [Thanatos-associated protein] domain-containing, apoptosis-associated protein 1) is a ubiquitously expressed member of a family of transcription factors with highly conserved DNA-binding and protein-interacting regions. Mutations in THAP1 cause dystonia, DYT6, a neurologic movement disorder. THAP1 downstream targets and the mechanism via which it causes dystonia are largely unknown. Here, we show that wild-type THAP1 regulates embryonic stem cell (ESC) potential, survival, and proliferation. Our findings identify THAP1 as an essential factor underlying mouse ESC survival and to some extent, differentiation, particularly neuroectodermal. Loss of THAP1 or replacement with a disease-causing mutation results in an enhanced rate of cell death, prolongs Nanog, Prdm14, and/or Rex1 expression upon differentiation, and results in failure to upregulate ectodermal genes. ChIP-Seq reveals that these activities are likely due in part to indirect regulation of gene expression.


Subject(s)
Cell Differentiation , Cell Survival , DNA-Binding Proteins/metabolism , Mouse Embryonic Stem Cells/cytology , Animals , Apoptosis , Cell Line , Cell Proliferation , DNA-Binding Proteins/genetics , Dystonia/genetics , Dystonia/metabolism , Gene Expression Regulation, Developmental , Mice , Mouse Embryonic Stem Cells/metabolism , Mutation
6.
Eur J Neurosci ; 43(5): 640-52, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26750440

ABSTRACT

Disturbance of homeostasis within the endoplasmic reticulum (ER) lumen leads to the accumulation of unfolded and misfolded proteins. This results in the activation of an evolutionary conserved stress response termed ER stress that, if unresolved, induces apoptosis. Previously the Bcl-2 homology domain 3-Only Protein Puma was identified as a mediator of ER stress-induced apoptosis in neurons. In the search of alternative contributors to ER stress-induced apoptosis, a downregulation of the anti-apoptotic Bcl-2 family protein Mcl-1 was noted during ER stress in both mouse cortical neurons and human SH-SY5Y neuroblastoma cells. Downregulation of Mcl-1 was associated with an upregulation of microRNA-29a (miR-29a) expression, and subsequent experiments showed that miR-29a targeted the 3'-untranslated region of the anti-apoptotic Bcl-2 family protein, Mcl-1. Inhibition of miR-29a expression using sequence-specific antagomirs or the overexpression of Mcl-1 decreased cell death following tunicamycin treatment, while gene silencing of Mcl-1 increased cell death. miR-29a did not alter the signalling branches of the ER stress response, rather its expression was controlled by the ER stress-induced transcription factor activating-transcription-factor-4 (ATF4). The current data demonstrate that the ATF4-mediated upregulation of miR-29a enhances the sensitivity of neurons to ER stress-induced apoptosis.


Subject(s)
Apoptosis , Endoplasmic Reticulum Stress , MicroRNAs/genetics , Neurons/metabolism , Up-Regulation , Activating Transcription Factor 4/genetics , Activating Transcription Factor 4/metabolism , Animals , Apoptosis Regulatory Proteins/genetics , Apoptosis Regulatory Proteins/metabolism , Cells, Cultured , HeLa Cells , Humans , Mice , Mice, Inbred C57BL , Myeloid Cell Leukemia Sequence 1 Protein/genetics , Myeloid Cell Leukemia Sequence 1 Protein/metabolism , Tumor Suppressor Proteins/genetics , Tumor Suppressor Proteins/metabolism
7.
Mol Pharm ; 11(11): 4270-9, 2014 Nov 03.
Article in English | MEDLINE | ID: mdl-25243784

ABSTRACT

The development of small interfering RNA (siRNA) to silence specific genes offers a new means of understanding and treating a range of respiratory diseases, including inflammatory lung disease. The alveolar macrophage (AM) is a key component of the inflammatory process in the lungs, associated with high levels of gene expression in inflammatory lung disease and therefore an attractive target for therapeutic siRNA. Delivery of siRNA to macrophages presents a significant delivery challenge, as fully differentiated alveolar macrophages are difficult to access and transfect. In this study we engineered particles suitable for inhalation that would efficiently transfect macrophages postinhalation. The process for encapsulation of siRNA in poly(lactic-co-glycolic acid) microparticles (MPs) was optimized using a double emulsion technique, and the resulting particles were characterized for size, shape, aerosol characteristics, encapsulation efficiency, and integrity of encapsulated siRNA. The cell uptake of the siRNA-loaded microparticles was determined by flow cytometry, confocal laser scanning microscopy (CLSM), and high-content analysis (HCA) with MPs capable of transfecting up to 55% of cells. Anti-TNFα siRNA-MPs were then prepared to study the functional activity of encapsulated siRNA in LPS-stimulated macrophages as a model of inflammation. The anti-TNFα siRNA-MPs were able to decrease TNFα expression by 45% over 48 h in the differentiated human monocytic cell line THP-1 compared to negligible knockdown using commercial transfection reagents and offered significant, sustained siRNA knockdown of TNFα in primary monocytes for up to 72 h.


Subject(s)
Bioengineering , Gene Silencing , Lactic Acid/chemistry , Leukemia, Monocytic, Acute/therapy , Macrophages, Alveolar/drug effects , Polyglycolic Acid/chemistry , RNA, Small Interfering/genetics , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Aerosols , Cell Differentiation , Cell Survival , Drug Carriers , Drug Delivery Systems , Emulsions , Humans , Infant , Inflammation/genetics , Inflammation/pathology , Inflammation/therapy , Leukemia, Monocytic, Acute/genetics , Leukemia, Monocytic, Acute/pathology , Lung Diseases/genetics , Lung Diseases/pathology , Lung Diseases/therapy , Macrophages, Alveolar/metabolism , Macrophages, Alveolar/pathology , Male , Microspheres , Polylactic Acid-Polyglycolic Acid Copolymer , RNA, Small Interfering/administration & dosage , Tumor Cells, Cultured , Tumor Necrosis Factor-alpha/genetics
8.
J Mol Neurosci ; 53(2): 231-41, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24696165

ABSTRACT

Endoplasmic reticulum (ER) stress has been implicated in a number of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). MicroRNAs are small ribonucleic acids which can modulate protein expression by binding to the 3'UTR of target mRNAs. We recently identified increased miR-29a expression in response to ER stress in neurons, with members of the miR-29 family implicated in cancer and neurodegeneration. We found high expression of miR-29a in the mouse brain and spinal cord by quantitative PCR analysis and increased expression of miR-29a in the spinal cord of SOD1(G93A) transgenic mice, a mouse model of familial ALS. In situ hybridisation experiments revealed increased miR-29a expression in the lumbar spinal cord of SOD1(G93A) transgenic mice from postnatal day 70 onward when compared to wild-type mice. miR-29a knockdown was achieved in the CNS in vivo after a single intracerebroventricular injection of a miR-29a-specific antagomir. While analysis of disease progression and motor function could not identify a significant alteration in ALS disease manifestations, a trend towards increased lifespan was observed in male SOD1(G93A) mice. These findings demonstrate that miR-29a may act as a marker for disease progression in SOD1(G93A) mice, and provide first proof-of-concept for a therapeutic modulation of miR-29a function in ALS.


Subject(s)
Amyotrophic Lateral Sclerosis/metabolism , MicroRNAs/metabolism , Amyotrophic Lateral Sclerosis/genetics , Amyotrophic Lateral Sclerosis/pathology , Animals , Brain/drug effects , Brain/metabolism , Male , Mice , Mice, Inbred C57BL , MicroRNAs/antagonists & inhibitors , MicroRNAs/genetics , Oligoribonucleotides/pharmacology , Spinal Cord/drug effects , Spinal Cord/metabolism , Superoxide Dismutase/genetics , Superoxide Dismutase/metabolism , Superoxide Dismutase-1
9.
New Phytol ; 202(2): 716-725, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24460533

ABSTRACT

The gene network that specifies flower shape in Antirrhinum majus (bilateral floral symmetry or zygomorphy) includes two MYB-class genes - RADIALIS (RAD) and DIVARICATA (DIV). RAD is involved in establishing the dorsal identity program and its role is to regulate the domain of activity of DIV (the ventral identity program) by restricting it to ventral regions of the flower. Plantago is in the same family as Antirrhinum but has small, radially symmetrical (actinomorphic) flowers derived from a zygomorphic ancestral state. Here we investigate the MYB-class floral symmetry genes and the role they have played in the evolution of derived actinomorphy in Plantago lanceolata. A DIV ortholog (PlDIV) but no RAD ortholog was identified in P. lanceolata. PlDIV is expressed across all petals and stamens later in flower development, which is consistent with the loss of RAD gene function. PlDIV expression in anther sporogenous tissue also suggests that PlDIV was co-opted to regulate cell proliferation during the early stages of pollen development. These results indicate that evolution of derived actinomorphy in Plantago involved complete loss of dorsal gene function, resulting in expansion of the domain of expression of the ventral class of floral symmetry genes.


Subject(s)
Evolution, Molecular , Flowers/growth & development , Gene Expression Regulation, Developmental , Gene Expression Regulation, Plant , Genes, Plant , Plantago/genetics , Transcription Factors/genetics , Genes, myb , Phenotype , Plant Proteins/genetics , Plantago/growth & development
10.
Acta Paediatr ; 100(7): e47-8, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21418105

ABSTRACT

UNLABELLED: We report a very rare case of methaemoglobinaemia associated with glucose 6 phosphate dehydrogenase (G6PD) deficiency, complicating a respiratory illness in a preterm neonate. This neonate had consistently low saturation readings despite being ventilated at moderately high pressures in 100% oxygen. An arterial blood gas confirmed a high methaemoglobin level and a high pO2, inconsistent with the saturations. In addition, the bilirubin increased to exchange levels and was difficult to control with quadruple phototherapy. A double volume exchange transfusion was performed, which reduced both bilirubin and methaemoglobin. The pulse oximetry then started to correlate well with pO2. G6PD deficiency was confirmed. CONCLUSION: Paediatricians should remember that methaemoglobinaemia is a rare but important cause of persistently low saturations, and exchange transfusion is a reliable treatment for this condition.


Subject(s)
Glucosephosphate Dehydrogenase Deficiency/complications , Methemoglobinemia/complications , Oxygen/blood , Respiratory Distress Syndrome, Newborn/etiology , Diagnosis, Differential , Exchange Transfusion, Whole Blood , Humans , Hyperbilirubinemia/therapy , Infant, Newborn , Infant, Premature , Male , Oxygen/administration & dosage , Phototherapy , Respiration, Artificial
SELECTION OF CITATIONS
SEARCH DETAIL
...